Skip to Main Content
Back to News

Insider Sale: President of $BAC Sells 148,391 Shares

Automated

James P DeMare, the President of $BAC, sold 148,391 shares of the company on 08-01-2025 for an estimated $6,761,732. We received data on the trade from a recent SEC filing. This was a sale of approximately 39.9% of their shares of this class of stock. Following this trade, they now own 223,407 shares of this class of $BAC stock.

$BAC Insider Trading Activity

$BAC insiders have traded $BAC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $BAC stock by insiders over the last 6 months:

  • JAMES P DEMARE (President, Global Markets) sold 148,391 shares for an estimated $6,761,732

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$BAC Hedge Fund Activity

We have seen 1,499 institutional investors add shares of $BAC stock to their portfolio, and 1,473 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$BAC Congressional Stock Trading

Members of Congress have traded $BAC stock 10 times in the past 6 months. Of those trades, 3 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $BAC stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$BAC Analyst Ratings

Wall Street analysts have issued reports on $BAC in the last several months. We have seen 12 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Oppenheimer issued a "Outperform" rating on 07/30/2025
  • Truist Securities issued a "Buy" rating on 07/09/2025
  • RBC Capital issued a "Outperform" rating on 06/30/2025
  • Citigroup issued a "Buy" rating on 06/26/2025
  • Morgan Stanley issued a "Overweight" rating on 06/23/2025
  • Goldman Sachs issued a "Buy" rating on 06/10/2025
  • Argus Research issued a "Buy" rating on 04/16/2025

To track analyst ratings and price targets for $BAC, check out Quiver Quantitative's $BAC forecast page.

$BAC Price Targets

Multiple analysts have issued price targets for $BAC recently. We have seen 15 analysts offer price targets for $BAC in the last 6 months, with a median target of $52.0.

Here are some recent targets:

  • Chris Kotowski from Oppenheimer set a target price of $57.0 on 07/30/2025
  • John McDonald from Truist Securities set a target price of $53.0 on 07/09/2025
  • Saul Martinez from HSBC set a target price of $51.0 on 07/08/2025
  • Gerard Cassidy from RBC Capital set a target price of $53.0 on 06/30/2025
  • David George from Baird set a target price of $52.0 on 06/27/2025
  • Keith Horowitz from Citigroup set a target price of $54.0 on 06/26/2025
  • Betsy Graseck from Morgan Stanley set a target price of $49.0 on 06/23/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles